CHISON

CHISON Medical Technologies Co., Ltd., founded by national-level ultrasound expert Mr. Mo Shanjue in 1996, has been dedicated to the ultrasound field for 26 years. It is committed to improving healthcare and creating value for human health through the research, development, and innovation of cutting-edge ultrasound technologies. Currently, the company possesses 40 core technologies, covering full-body application ultrasound, specialized ultrasound, intelligent ultrasound, and probe core components, with nearly 500 intellectual property rights obtained both domestically and internationally (as of the end of 2021). Its self-developed and manufactured products are sold in over 100 countries and regions worldwide, earning widespread market recognition. On December 3, 2019, CHISON successfully listed on the STAR Market (stock code: 688358), becoming the first ultrasound company on China's STAR Market. The company consistently focuses on addressing clinical pain points, deeply cultivating specialized fields, and has formed significant competitive advantages in specialization, portability, and intelligence. As a Chinese medical device enterprise, CHISON actively fulfills the mission of strengthening national strategic scientific and technological power, building a nationally influential brand, and is determined to become a global leader in ultrasound development trends.